- Home
- VHI vs VSTM Comparison
VHI vs VSTM Comparison
Compare VHI & VSTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHI
- VSTM
- Stock Information
- Founded
- VHI 1932
- VSTM 2010
- Country
- VHI United States
- VSTM United States
- Employees
- VHI N/A
- VSTM N/A
- Industry
- VHI Major Chemicals
- VSTM Biotechnology: Pharmaceutical Preparations
- Sector
- VHI Industrials
- VSTM Health Care
- Exchange
- VHI Nasdaq
- VSTM Nasdaq
- Market Cap
- VHI 454.3M
- VSTM 531.1M
- IPO Year
- VHI N/A
- VSTM 2012
- Fundamental
- Price
- VHI $16.30
- VSTM $9.25
- Analyst Decision
- VHI Sell
- VSTM Strong Buy
- Analyst Count
- VHI 1
- VSTM 8
- Target Price
- VHI $12.00
- VSTM $12.43
- AVG Volume (30 Days)
- VHI 12.2K
- VSTM 2.9M
- Earning Date
- VHI 08-07-2025
- VSTM 08-07-2025
- Dividend Yield
- VHI 1.94%
- VSTM N/A
- EPS Growth
- VHI 269.89
- VSTM N/A
- EPS
- VHI 3.44
- VSTM N/A
- Revenue
- VHI $2,093,500,000.00
- VSTM $2,137,000.00
- Revenue This Year
- VHI $22.20
- VSTM $86.06
- Revenue Next Year
- VHI $7.66
- VSTM $395.22
- P/E Ratio
- VHI $4.80
- VSTM N/A
- Revenue Growth
- VHI 4.04
- VSTM N/A
- 52 Week Low
- VHI $14.10
- VSTM $2.34
- 52 Week High
- VHI $41.75
- VSTM $9.43
- Technical
- Relative Strength Index (RSI)
- VHI 46.49
- VSTM 73.31
- Support Level
- VHI $15.82
- VSTM $8.71
- Resistance Level
- VHI $17.67
- VSTM $9.43
- Average True Range (ATR)
- VHI 0.84
- VSTM 0.61
- MACD
- VHI 0.02
- VSTM 0.08
- Stochastic Oscillator
- VHI 38.84
- VSTM 90.95
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.